A Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System Tumors

The authors present a cohort of 661 young adult glioblastomas diagnosed using 2016 WHO World Health Organization Classification of Tumors of the Central Nervous System, utilizing comprehensive genomic profiling (CGP) to explore their genomic landscape and assess their relationship to currently defin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The oncologist (Dayton, Ohio) Ohio), 2024-01, Vol.29 (1), p.e47-e58
Hauptverfasser: Haberberger, James F, Pegram, Worthy, Britt, Nicholas, Schiavone, Kelsie, Severson, Eric, Sharaf, Radwa, Albacker, Lee A, Williams, Erik, Lechpammer, Mirna, Hemmerich, Amanda, Lin, Douglas, Huang, Richard S P, Hiemenz, Matthew, Elvin, Julia, Graf, Ryon, Lesser, Glenn, Kram, David, Strowd, Roy, Bi, Wenya Linda, Ramkissoon, Lori A, Cohen, Michael B, Reddy, Prasanth, Creeden, James, Ross, Jeffrey S, Alexander, Brian M, Ramkissoon, Shakti H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The authors present a cohort of 661 young adult glioblastomas diagnosed using 2016 WHO World Health Organization Classification of Tumors of the Central Nervous System, utilizing comprehensive genomic profiling (CGP) to explore their genomic landscape and assess their relationship to currently defined disease entities. This analysis explored variants with evidence of pathogenic function, common copy number variants (CNVs), and several novel fusion events not described in literature. Tumor mutational burden (TMB) mutational signatures, anatomic location, and tumor recurrence are further explored. Using data collected from CGP, unsupervised machine-learning techniques were leveraged to identify 10 genomic classes in previously assigned young adult glioblastomas. The authors relate these molecular classes to current World Health Organization guidelines and reference current literature to give therapeutic and prognostic descriptions where possible.
ISSN:1083-7159
1549-490X
DOI:10.1093/oncolo/oyad224